NaturalShrimp in receivership; lenders buy assets, liquidation imminent, shareholders wiped out

NaturalShrimp Incorporated (OTCBB: SHMP)

Quick take: The company is in receivership, has sold substantially all operating assets to its lenders, and is transitioning to liquidation accounting. The business shows revenue but sustained losses, heavy non‑cash charges, huge liabilities and a deep stockholders' deficit.

* Receivership & asset sale: Receiver appointed Sept 2024; Sale motion approved Mar 30, 2025; title to assets transferred May 14, 2025. Purchase consideration: $35,703,789.87 credit bid and $100,000 cash.

* Liquidation posture: Company will present financials on the liquidation basis as of the convenience date (liquidation considered imminent as of Mar 31, 2025).

* Balance sheet snapshot (Dec 31, 2024): Total assets $25,035,488; Total liabilities $41,148,487; Stockholders' deficit $(62,473,015); Accumulated deficit $(190,439,418).

* Liquidity: Cash $20,981 at Dec 31, 2024; Working capital deficiency $40,860,138 (MD&A).

* Debt / defaults: Company reports defaulted debt obligations totaling approximately $29.9 million. Notable balances (Dec 31, 2024): Restructured Senior note payable $27,600,000; Restructured August note payable $2,790,000; January 2023 note ~ $221,000.

* Revenues & volume: Sales - three months ended Dec 31, 2024: $56,501 (prior year $101,302). Nine months ended Dec 31, 2024: $163,492 (prior year $365,184). Net revenue (three months) $24,280; (nine months) $45,781.

* Share count / dilution: 1,277,546,746 common shares outstanding as of Sept 10, 2025; Weighted average shares outstanding (basic & diluted) nine months: 1,120,423,669.

* Non‑cash charges: Depreciation nine months $1,295,289; Amortization nine months $1,102,500.

Income statement - Positive points

* Revenues exist: Company continued shrimp sales (three months $56,501; nine months $163,492) - product market activity, albeit low.

* Reduced operating loss vs prior year: Net loss for nine months improved from $(10,347,034) (2023) to $(6,285,201) (2024), largely aided by fair‑value changes and one‑time items.

* Operating cash burn improved: Cash used in operating activities for nine months was $(2,112,033), an improvement vs prior year $(2,857,801).

* Financing activity provided cash: $1,899,777 cash provided by financing in the nine months ended Dec 31, 2024.

Income statement - Negative points

* Persistent net losses: Net loss - three months ended Dec 31, 2024: $(2,370,724); nine months: $(6,285,201). Loss per share (nine months) $(0.01).

* Very low gross revenue and declining sales: Sales down materially vs prior periods (three months $56,501 vs $101,302 prior year).

* Heavy operating expenses vs revenue: Total operating expenses three months $2,050,194 vs net revenue $24,280 - operating losses driven by G&A, salaries, professional services.

* Large interest & financing costs: Interest expense nine months $(355,039) plus related party interest; restructured notes carry large fair‑value interest components (restructured notes fair value totaled $30,390,000 at Dec 31, 2024).

* Non‑recurring fair‑value volatility previously masked results: Fair value changes of restructured notes and warrant liabilities produced large swings in "other income/(expense)" in prior periods; warrants written down to $0 at Dec 31, 2024.

What this means for investors / stakeholders

* Creditors gained control of core assets; the asset sale extinguished roughly $31.2M of debt in exchange for fixed assets, patents and license agreements (book total $24.7M at Dec 31, 2024). That reduces the company's debt load but leaves common shareholders effectively unprotected in a liquidation.

* Small cash balance ($20,981) and continuing losses mean the company cannot fund operations or meaningful recovery without capital; liquidation is the principal outcome per management disclosures.

* Significant dilution already occurred (1.28B shares outstanding) and preferred/temporary mezzanine equity exists (Series F carrying $43,612,000; temporary equity $861,792), further complicating recoveries for common holders.

Bottom line: NaturalShrimp (OTCBB: SHMP) has active revenue but is insolvent in practice-in receivership, assets sold to lenders, large liabilities and sustained losses. The asset sale and liquidation accounting mean creditors are first in line; common shareholders face near‑zero recovery unless unexpected events change the process.